Ricerca avanzata

Home > Riviste > Panminerva Medica > Fascicoli precedenti > Panminerva Medica 2004 Marzo;46(1) > Panminerva Medica 2004 Marzo;46(1):49-59



Rivista di Medicina Interna

Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,6

Periodicità: Trimestrale

ISSN 0031-0808

Online ISSN 1827-1898


Panminerva Medica 2004 Marzo;46(1):49-59


Stem cells in gynecology and obstetrics

Perillo A. 1,2, Bonanno G. 1,2, Pierelli L. 3,4, Rutella S. 2,5, Scambia G. 1,6, Mancuso S. 1

1 Department of Gynecology and Obstetrics Catholic University of the Sacred Heart, Rome, Italy
2 UNICATT Cord Blood Bank Catholic University of the Sacred Heart, Rome, Italy
3 Immunohematology and Transfusion Service ASL Viterbo, Viterbo, Italy
4 Mediterranean Institute of Neurology NEUROMED Pozzilli (IS), Italy
5 Department of Hematology and Blood Transfusion Catholic University of the Sacred Heart, Rome, Italy
6 Department of Oncology, Catholic University of the Sacred Heart, Campobasso, Italy

Over the past 10 years, we have become involved in a new research effort and an increasing scientific interest in the field of stem cell-based therapy. We are therefore able to describe different areas in which stem cell research can be applied and developed in gynecology and obstetrics. I) Hematopoietic stem cells have been used to set up therapeutic strategies for the treatment of gynecological solid tumors such as ovarian cancer. In this context different autologous or allogeneic transplantation approaches have been proposed and clinically investigated. II) Umbilical cord blood, which was often considered a waste material of the delivery, actually represents a precious source of stem cells that can be used for cell-based treatments of malignancies and inherited diseases. III) A feto-maternal cell traffic has recently been demonstrated through the placental barrier during pregnancy. This cellular exchange also includes stem cells from the fetus, which can generate microchimerisms in the mother and contribute to tissue repair mechanisms in different maternal organs. IV) Stem cells can be used for prenatal transplantation to treat different severe congenital diseases of the fetus. Nevertheless, several problems need to be solved to achieve an efficient in utero stem cell transplantation. Recent reports have pointed out the importance of timing in prenatal stem cell transplantation procedures and have shown the advantage of an early stem cell injection. An ultrasound-guided intracelomic approach could allow this possibility.

lingua: Inglese


inizio pagina